ClinicalTrials.gov record
Completed Phase 4 Interventional Results available

Efficacy and Safety Study of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

ClinicalTrials.gov ID: NCT05217927

Public ClinicalTrials.gov record NCT05217927. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 10, 2026, 5:23 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 4 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant in Episodic Migraine Prevention With Multiple Dosing Regimens

Study identification

NCT ID
NCT05217927
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Pfizer
Industry
Enrollment
1,415 participants

Conditions and interventions

Conditions

Interventions

  • Placebo comparator dosing Drug
  • Rimegepant 75mg daily dosing Drug
  • Rimegepant 75mg every other day dosing Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 3, 2022
Primary completion
Oct 21, 2024
Completion
Dec 10, 2024
Last update posted
Dec 15, 2025

2022 – 2024

United States locations

U.S. sites
30
U.S. states
18
U.S. cities
30
Facility City State ZIP Site status
AMR Clinical Tempe Arizona 85281
Axiom Research, Llc Colton California 92324
Clinical Research Institute Los Angeles California 90048
Wr-Pri, Llc Newport Beach California 92660
California Neuroscience Research Medical Group, inc. Sherman Oaks California 91403
Neurology Offices of South Florida, PLLC Boca Raton Florida 33428
AppleMed Research Group, LLC Miami Florida 33126
Clinical Investigation Specialists, Inc. Gurnee Illinois 60031
MediSphere Medical Research Center, LLC Evansville Indiana 47714
Collective Medical Research Overland Park Kansas 66210
Clinvest Research, LLC Springfield Missouri 65807
Alliance for Multispecialty Research, LLC Las Vegas Nevada 89119
Dent Neurosciences Research Center, Inc. Amherst New York 14226
Montefiore Medical Center The Bronx New York 10461
Upstate Clinical Research Associates, LLC Williamsville New York 14221
Wellnow Urgent Care and Research Columbus Ohio 43228
Hometown Urgent Care and Research Huber Heights Ohio 45424
Velocity Clinical Research, Medford Medford Oregon 97504
Preferred Primary Care Physicians, Inc. Pittsburgh Pennsylvania 15236
Velocity Clinical Research - Providence East Greenwich Rhode Island 02818
Velocity Clinical Research - Columbia Columbia South Carolina 29204
Velocity Clinical Research, Gaffney Gaffney South Carolina 29340
Tribe Clinical Research LLC Greenville South Carolina 29607
Clinical Research Associates, Inc. Nashville Tennessee 37203
FutureSearch Trials of Neurology Austin Texas 78731
FutureSearch Trials of Dallas, LP Dallas Texas 75231
Texas Center for Drug Development, Inc. Houston Texas 77081
APD Clinical Research Magnolia Texas 77355
Wasatch Clinical Research , LLC(Administrative Location) Salt Lake City Utah 84107
Seattle Clinical Research Center Seattle Washington 98105

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 77 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05217927, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 15, 2025 · Synced May 10, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT05217927 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →